<code id='F1C335FEF3'></code><style id='F1C335FEF3'></style>
    • <acronym id='F1C335FEF3'></acronym>
      <center id='F1C335FEF3'><center id='F1C335FEF3'><tfoot id='F1C335FEF3'></tfoot></center><abbr id='F1C335FEF3'><dir id='F1C335FEF3'><tfoot id='F1C335FEF3'></tfoot><noframes id='F1C335FEF3'>

    • <optgroup id='F1C335FEF3'><strike id='F1C335FEF3'><sup id='F1C335FEF3'></sup></strike><code id='F1C335FEF3'></code></optgroup>
        1. <b id='F1C335FEF3'><label id='F1C335FEF3'><select id='F1C335FEF3'><dt id='F1C335FEF3'><span id='F1C335FEF3'></span></dt></select></label></b><u id='F1C335FEF3'></u>
          <i id='F1C335FEF3'><strike id='F1C335FEF3'><tt id='F1C335FEF3'><pre id='F1C335FEF3'></pre></tt></strike></i>

          leisure time

          leisure time

          author:fashion    Page View:75155
          Person wearing a blue glove holding money against a blue backdrop.
          Adobe

          Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

          Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

          advertisement

          In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more
          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds
          Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

          AdobeTheFoodandDrugAdministrationsaidMondaythatithasdeepreservationsaboutNurOwn,aninvestigationalALS

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Dog Aging Project founders on what lies ahead after losing funding

          CelebratingabirthdayatHappyBarkDay,thefirstdogcafeintheGulfemirateofDubai.KARIMSAHIB/AFPviaGettyImag